FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD), today announced clinica…
Author: Business Wire
Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel)
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and Drug Administration (FDA), has approved ENCELTO™ (re…
MediPrint Ophthalmics Expands Clinical Program to Address Contact Lens Dropout Due to Discomfort
SAN DIEGO–(BUSINESS WIRE)–MediPrint Ophthalmics Expands Clinical Program to Address Contact Lens Dropout Due to Discomfort
Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
RALEIGH, N.C.–(BUSINESS WIRE)–Lumata Health, the leader in personalized support for patients with vision-threatening chronic eye diseases, today announced that it has raised $23 million in Series B funding to accelerate its mission of eliminating pre…
MyEyeDr. and Tory Burch Partner on New Frames for Spring
VIENNA, Va.–(BUSINESS WIRE)–MyEyeDr., a leading provider of eye health services with more than 880 locations across the U.S., is partnering with American luxury brand Tory Burch to launch two new frame styles for spring. Part of Tory Burch’s Spring 2…
Eye Health America Expands into Central Georgia with the Acquisition of Eye Center of Central Georgia
MACON, Ga.–(BUSINESS WIRE)–Eye Health America (EHA), a prominent integrated eye care provider in the Southeastern United States, is pleased to announce its partnership with the Eye Center of Central Georgia (ECCG) today. This represents EHA’s 30th pa…
Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Monday, M…
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Wat…
Alcon Canada renforce son engagement envers les patients atteints d’astigmatisme en offrant les lentilles cornéennes TOTAL30 pour l’astigmatisme dans de nouveaux paramètres élargis
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui l’ajout de paramètres élargis à la gamme de lentilles TOTAL30MD pour l’as…
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business …
GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Seoul Semiconductor Presents a New Paradigm in Lighting with Natural Light Technology
SEOUL, South Korea–(BUSINESS WIRE)– #Acrich–Seoul Semiconductor will participate in JAPAN SHOP 2025, focusing on ‘SunLike’ LED technology under the theme ‘Lighting’s Paradigm Shift.’
ソウル半導体、自然光技術で照明の新たなパラダイムを提案
韓国ソウル–(BUSINESS WIRE)–（ビジネスワイヤ） — グローバル光半導体専門企業であるソウル半導体（KOSDAQ：046890）が、新たな光のパラダイムとなる自然光技術（太陽光）とディスプレイを提案します。ソウル半導体は、3月4日から7日まで東京ビッグサイトで開催される日本最大規模の商業空間デザイン・ディスプレイ専門展示会「JAPAN SHOP 2025」に出展すると、27日に発表しました。 今回の展示会では、「照明のパラダイムシフト」をテーマに、革新的な技術「SunLike」L…
STAAR Surgical Announces Leadership Transition
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farr…
ForSight Robotics Achieves ISO 13485:2016 Certification
YOKNEAM ILLIT, Israel–(BUSINESS WIRE)– #ISOCertification–ForSight Robotics achieves ISO 13485:2016 certification, an international benchmark for quality management systems in the medical device industry.
National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended December 28, 2024, and is providing its outlook for fiscal…
National Vision Appoints Christopher Laden as Chief Financial Officer
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the appointment of Christopher Laden as Chief Financial Officer, effective March 31, 2025. He will succeed Melissa Rasmussen…
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
ZÜRICH–(BUSINESS WIRE)–CDR-Life today announced the achievement of the fifth milestone under its collaboration and licensing agreement with Boehringer Ingelheim in the advancement of BI 771716, a novel therapeutic candidate for the treatment of geogr…